Intelligence · Clinical Development
Pipeline search results
Programs matching “treatment” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 270 pipeline programs matching "treatment" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Algorithm Treatment
BRIGHT MINDS BIOSCIENCES INC.
HIV
1 trial -
Bismuth-based susceptibility-guided treatment
Hospital Authority, Hong Kong
Helicobacter Pylori
1 trial -
Ciprofol
The First People's Hospital of Lianyungang
ECMO Treatment
1 trial -
Crysvita (burosumab-twza) Treatment
Ultragenyx UK Limited
Epidermal Nevus Syndrome
1 trial -
DS-8201a
AstraZeneca AB
Treatment of patients with HER2-positive breast cancer with or without brain metastasis
1 trial -
Daratumumab and corticosteroid treatment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acquired Hemophilia
1 trial -
Diane-35 pretreatment
The First People's Hospital of Lianyungang
Polycystic Ovary Syndrome
1 trial -
Henagliflozin Proline Tablets treatment
The First People's Hospital of Lianyungang
Diabetes Type 2
1 trial -
ICI22/00054
The George Institute
patients who are requested a colonoscopy for any indication and are under antiplatelet treatment (except ASA) or anticoagulant treatment
1 trial -
Ketamine
Teva Pharma GmbH
Treatment Resistant Depression
1 trial -
NL6220204217
Disc Medicine
HAMLETT compares regular treatment guidelines for patients in remission after a first episode of psychosis, namely continuation with antipsychotic medication for at least one year, with early dose reduction/discontinuation.
1 trial -
Optimal hypoglycemic treatment
The First People's Hospital of Lianyungang
Type2 Diabetes
1 trial -
PHARBEVACOL
Tour Hekla
1st line treatment for unresectable metastatic colorectal cancer
1 trial -
RC-P0055
The George Institute
Adults patients suffering from rheumatoid arthritis and in adequate response to one or two targeted treatments.
1 trial -
Rapid Acting insulin with pre-treatment of rHuPH20
HALOZYME THERAPEUTICS, INC.
Type 1 Diabetes Mellitus
1 trial -
Reinforcement Based Treatment
BRIGHT MINDS BIOSCIENCES INC.
Drug Abuse
1 trial -
Telbivudine treatment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chronic Hepatitis B
1 trial -
The papillon study
Pierre Fabre Australia Pty Ltd
giving a commercially available vaccine to women with HIV under treatment, women living with HIV traeted by antiretroviral
1 trial -
Treatment Algorithm A
Takeda
Colitis, Ulcerative
1 trial -
Treatment group
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hypertension
1 trial -
biologics treatment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Psoriasis
1 trial -
physiotherapeutic treatment
Universal Integrated
Morquio's Disease
1 trial -
treatment with CAZ-AVI
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Patients With Critically Ill Infections
1 trial -
Antioxidant
AYTU BIOPHARMA, INC
Compare the sORP Rate in Sperm Samples, Obtained by the Mioxsys System, Before and After 2.5 Months Antioxidant Men Supplements Treatment (Fertybiotic Man)
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.